Granulomatous Disease: What It Means

Granulomatous disease is a broad description of conditions in which clusters of inflammatory cells, called granulomas, form in body tissues. It is not one diagnosis with one treatment. If the term appears on a scan or biopsy report, the important next questions are what caused the finding, whether it is active, and whether it is affecting an organ. A report alone cannot answer all three. [1]

This guide explains the difference between a granuloma found during testing and chronic granulomatous disease, the inherited immune disorder often shortened to CGD. It also helps you prepare for a follow-up appointment, understand why infection testing matters, and recognize symptoms that should not wait. Use it to discuss your results with a clinician, not to diagnose yourself or change prescribed treatment.

Start here: Ask your clinician to identify the exact phrase in your report. “Calcified granuloma,” “granulomatous inflammation,” “sarcoidosis,” and “chronic granulomatous disease” do not mean the same thing. Write down whether you have a confirmed diagnosis, a suspected explanation, or a finding that still needs investigation.

A finding is not the same as CGD

What a granuloma describes

A pathologist examines tissue under a microscope and may describe a granulomatous pattern. That pattern helps narrow the investigation, but different diseases can produce overlapping appearances. Sarcoidosis, for example, is diagnosed through the clinical picture, supporting findings and exclusion of other causes, rather than a unique granuloma appearance. The wording “consistent with” or “suggestive of” should be read together with the clinician’s final assessment, not treated as proof by itself. [1]

What chronic granulomatous disease describes

Chronic granulomatous disease is a specific genetic immune disorder. Certain infection-fighting cells cannot reliably kill particular bacteria and fungi, making repeated or serious infections more likely. Excessive inflammation can also affect organs. Symptoms often begin in childhood, but later presentation is possible. Infections can involve the lungs, skin, liver and lymph nodes; inflammation can involve the digestive or urinary tract. This is different from finding an old granuloma on a chest scan in someone without this immune defect. Having a granuloma does not automatically mean that a person has inherited CGD. If your records actually say CGD, ask for the name of the immunology team managing it and the plan for infection prevention. The accompanying video on this page focuses on inherited CGD, not every condition that produces granulomas. [2]

Old granulomas versus active disease

A small lung nodule may be the leftover mark of a healed infection or another noncancerous process. Many are discovered on imaging done for an unrelated reason. A radiology report may describe a nodule as likely granulomatous, but a nodule is an imaging finding, not automatically a biopsy-proven granuloma. Clinicians review its size, appearance, previous scans and your personal risk factors to decide whether further imaging or tissue sampling is appropriate. Small nodules often cause no symptoms. Bringing an older chest scan can be useful because comparison may show that a finding has been stable. Do not assume every nodule is cancer, but do not ignore an advised follow-up because a report contains the reassuring word “granuloma.” Ask whether the recommended next step is no further assessment, repeat imaging or additional investigation. [3]

An example of cause-specific care comes from the 2025 IDSA histoplasmosis guideline. For certain asymptomatic nodules attributable to previous Histoplasma infection, routine antifungal treatment is not suggested when there is no evidence of active disease elsewhere. The guideline specifically advises against treatment for patients with only calcified pulmonary nodules. People at higher risk of severe or disseminated infection may need closer monitoring or consideration of treatment. This does not create a universal rule that every calcified lesion is harmless or that every noncalcified nodule needs medicine. It explains why the original infection, current immune status and evidence of activity matter. If you are about to start immune-suppressing treatment, make sure the prescriber knows about previous fungal infection and relevant imaging findings. [4]

When to get urgent help

Seek emergency medical help for severe breathing difficulty, new confusion, difficulty waking, or blue, grey or markedly pale skin or lips in someone who is acutely unwell. A serious reaction to infection called sepsis can develop quickly. It does not require every symptom to be present, and absence of a high fever is not reliable reassurance. In children, unusual drowsiness, poor responsiveness, breathing difficulty or a striking change from normal behavior deserves immediate attention. Call your local emergency number rather than waiting for a routine appointment or an online reply. Explain any known immune disorder and bring a medication list if possible. These warning signs are about the person’s current condition, not whether the exact cause of a granuloma has already been established. [5]

For less dramatic but persistent changes, contact the team evaluating you and ask how quickly you should be assessed. Give concrete information: when the symptom started, whether it is worsening, what you can no longer do, and any measured temperature. A useful message is more specific than “my granulomas are worse.” If your team has given an individualized urgent-care plan, follow that plan. Do not use a reassuring result from an earlier visit to dismiss a new, severe symptom.

Symptoms depend on the organ and cause

Lungs, eyes and skin

Sarcoidosis illustrates why a granulomatous condition can look different from one person to another. Lung involvement may cause cough, shortness of breath or chest discomfort. Other people develop skin changes, enlarged lymph nodes, eye symptoms or fatigue, while some have few noticeable symptoms. The location of inflammation matters more than the general label. Tell the clinician about problems outside the organ that was originally tested, including eye discomfort or changes in vision. Do not assume that a skin finding and a breathing problem are unrelated, but equally do not assume one diagnosis explains every new complaint. For a closer look at this particular condition, read our guide to sarcoidosis symptoms. It complements, rather than replaces, an assessment of your own findings. [6]

Symptoms that raise concern for infection

Active tuberculosis can cause a persistent cough, chest pain, coughing up sputum or blood, fever, night sweats, poor appetite, fatigue and weight loss. Symptoms vary when infection is outside the lungs. These complaints are not specific enough to diagnose TB, but a prolonged cough with systemic symptoms should be assessed, particularly after a relevant exposure. Inactive, or latent, TB is different: people do not have symptoms of TB disease and cannot spread TB to others. If TB is being considered, tell the clinic before arriving so it can advise on precautions. Our tuberculosis guide explains the distinction in more detail. Finding a granuloma does not by itself establish whether someone has active TB or is contagious. [7]

Digestive and other symptoms

Crohn’s disease is a chronic inflammatory bowel condition that can affect different parts of the digestive tract. A person may have flares and periods of remission rather than continuous symptoms. Its complications can include anemia, poor nutrition, abscesses, fistulas and bowel narrowing or obstruction. Children may have problems with growth or development. Inflammation may also affect areas outside the bowel, including the joints, skin and eyes. Therefore, persistent digestive symptoms deserve their own assessment rather than being attributed to a vague diagnosis of “granulomatous disease.” Tell your clinician about weight changes, blood in stools, pain, vomiting and changes in how often you use the bathroom. A symptom diary can help organize that conversation, but it should not delay care for a significant deterioration. [8]

The main groups of causes

The following comparison is a starting point for discussion, not a way to identify your diagnosis from one symptom. More than one explanation may need consideration. Ask which possibilities are genuinely relevant to your history instead of requesting every available test.

Different findings require different next steps
Situation	Key distinction	Useful question
Old lung nodule	Prior imaging may clarify stability. [3]	Is any follow-up needed?
Possible infection	The organism and disease activity matter. [9]	Which samples are being tested?
Possible inflammatory disease	Other causes must be considered. [1]	What supports this diagnosis?
Confirmed inherited CGD	Immune function requires specialist care. [27]	What is my infection action plan?

Tuberculosis and related bacteria

When TB infection is suspected, a blood or skin test is only part of the assessment. A positive result prompts evaluation to distinguish inactive infection from active disease. That evaluation can involve the medical history, examination, chest imaging and tests of sputum or other samples. A negative infection test does not always end the investigation, particularly if symptoms, recent exposure or immune problems make TB plausible. Treatment for active TB generally uses several medicines, and completing the prescribed course is important. Do not borrow antibiotics, start leftover tablets or stop a regimen because a cough improves. If you have previously been treated, provide the drug names and dates when you can, rather than simply saying that an old scan showed TB. [9]

Nontuberculous mycobacteria, or NTM, are a different group of bacteria found in soil, water and dust. They are not the bacteria that cause tuberculosis. They can cause lung, skin, soft-tissue or other infections, with greater risk in some people who have existing lung disease or weakened immunity. Symptoms depend on the affected site and can include cough, weight loss, fatigue or skin changes. NTM infections do not typically spread from person to person. Treatment often requires specialist input and a combination of antibiotics, sometimes for a prolonged period. A plan appropriate for one species or body site may be wrong for another. Ask for the organism’s full name if an NTM result is reported, and clarify whether the team considers it evidence of disease in your situation. [10]

Fungal infections

Histoplasmosis results from inhaling spores of Histoplasma from the environment. Soil enriched by bird or bat droppings can be a source, and activities such as cave exploration, construction or cleaning contaminated areas may be relevant. The infection can resemble other respiratory illnesses. Severe or disseminated disease is more likely in people with certain immune problems. Diagnosis may use antigen testing, antibody testing, culture or microscopy, depending on the circumstances. A mild infection and disease that spreads beyond the lungs do not require the same approach. Antifungal treatment is used for important moderate-to-severe, chronic or disseminated forms; some mild acute infections resolve without it. Mention both current and previous travel, because the place where you live now may not be the place where exposure happened. [11]

Valley fever, also called coccidioidomycosis, is another infection acquired from environmental fungi. It is associated with parts of the southwestern United States and other regions of the Americas. It can cause cough, tiredness, breathlessness, fever-like illness or a rash, and occasionally spreads beyond the lungs. Blood tests for antibodies are commonly used in diagnosis, with other specimen tests selected when needed. A history of time in an affected area can be useful even if you cannot remember a dramatic dust exposure. Tell your clinician about seasonal residence, work trips and outdoor activities, not only international travel. Geography helps guide the investigation, but symptoms and laboratory evidence remain important; a travel history alone is not a diagnosis. [12]

Workplace and inhaled exposures

Chronic beryllium disease is a granulomatous lung disease associated with an immune response to beryllium exposure. It can resemble sarcoidosis, making a detailed work history important. Exposure may occur in jobs involving beryllium-containing materials, and symptoms can arise long after the exposure began. Cough, breathlessness and fatigue are among the possible symptoms. Clinicians may assess beryllium sensitization as part of the investigation. Explain the materials you handled, the processes used and whether dust or fumes were present, rather than giving only a job title. If occupational exposure is plausible, ask whether occupational medicine advice is appropriate. Workplace exposure control is a practical part of prevention, but leaving an exposure does not guarantee that an established illness will immediately disappear. [13]

Hypersensitivity pneumonitis is an immune reaction in the lungs after breathing certain environmental substances. Relevant settings can include birds, mold, humidifiers, hot tubs, farming and some industrial work. The timing of symptoms may be abrupt after exposure or gradual over a longer period. Persistent inflammation can lead to permanent lung damage. Identifying and avoiding the responsible substance is often a central part of treatment, with medicines or other support considered according to severity. Report whether symptoms improve away from home or work, while recognizing that this observation cannot establish the diagnosis. Avoid deliberately exposing yourself again to “test” a suspected trigger. Discuss a safe investigation with the respiratory team, especially before making costly changes to your home or employment. [14]

Foreign material and blood-vessel inflammation

Some granulomas arise around material placed in the body. The FDA lists nodules or granulomas among the possible complications of dermal fillers, alongside infection and other adverse effects. A lump near an injection site therefore needs an assessment of what was injected, where and when, rather than an assumption that it represents a body-wide immune disease. Keep treatment records and product details if available. Tell the clinician about cosmetic procedures even if they happened some time ago or were performed elsewhere. Do not attempt to squeeze, cut or inject an unexplained lump yourself. The appropriate response depends on the cause, and treatment for a foreign-material reaction is not interchangeable with treatment for an infection. [15]

Granulomatosis with polyangiitis, or GPA, is a form of blood-vessel inflammation that can affect the nose, sinuses, ears, lungs and kidneys. It is different from both sarcoidosis and inherited CGD. Persistent sinus problems, nosebleeds, respiratory symptoms or evidence of kidney involvement may prompt investigation. There is no single definitive test for every patient; assessment can include blood tests such as ANCA, urine testing, imaging and a biopsy. Specialist treatment depends on severity and which organs are threatened, with an initial phase to bring disease under control and subsequent care to maintain control. The important point is not to identify GPA from its long name or a positive antibody alone, but to understand how the full clinical evidence fits together. [16]

How clinicians investigate granulomas

Read the pathology words carefully

“Necrotizing” means that tissue death is present within the sampled inflammatory pattern; “non-necrotizing” means that this feature was not identified in that sample. These terms can guide the differential diagnosis, but neither proves a particular cause. Sarcoid granulomas can occasionally contain limited necrosis, and infections must remain part of the assessment when appropriate. Pathologists may use special stains to look for organisms, while microbiological studies and cultures provide additional information. Ask whether the report is final and whether cultures or other studies are still pending. A preliminary stain result and the completed investigation are not necessarily the same thing. It is reasonable to ask the clinician to explain how much confidence the team has in the proposed diagnosis and what findings would cause them to reconsider it. [34]

In suspected sarcoidosis, clinicians consider symptoms, examination, imaging and sometimes biopsy findings while ruling out other conditions. Tests may also assess organ function rather than simply look for more granulomas. Depending on the situation, this can include blood tests, eye examination, breathing tests or heart investigations. Eye involvement may exist without obvious symptoms, which is one reason an organ assessment may be recommended even when you feel relatively well. Not everyone needs every listed test. Ask what each investigation is meant to answer and whether the result would change your care. If different specialists are involved, request a clear summary stating which organs are affected, which have been checked, and which findings still need clarification. [17]

Breathing tests and bronchoscopy

Pulmonary function tests measure how the lungs work. Spirometry assesses how much air you can breathe out and how quickly; other tests measure lung volume or gas transfer. Exercise-based assessments can add information about function during activity. These measurements answer different questions from an X-ray or CT scan, which shows structure. They may help establish a baseline and monitor change over time in conditions that affect the lungs. Follow the testing unit’s preparation instructions and ask whether you should take your usual inhalers beforehand. When reviewing results, ask about the trend and its significance rather than interpreting a single percentage without context. A useful follow-up question is whether the measured change matches your symptoms and whether another explanation needs consideration. [18]

Bronchoscopy uses a thin camera-equipped tube to examine the airways. It can allow tissue sampling or bronchoalveolar lavage, in which saline is used to collect a fluid sample from the lungs. Samples may help investigate infection or other lung disease. The procedure does not simply “remove the granulomas”; its role is usually to obtain information or address a specific airway problem. Ask about the proposed samples, sedation, preparation and expected recovery. Tell the team about all medicines, but do not stop them without instructions. If you receive sedation, arrange for someone to take you home. The team should explain relevant risks and tell you which symptoms after the procedure require prompt contact, rather than leaving you to judge these from a general online guide. [19]

Why some results take longer

For suspected TB, clinicians may combine microscopy, nucleic acid testing, culture and drug-susceptibility testing. These methods provide different information and do not all return at the same speed. Imaging can support suspicion but cannot definitively diagnose TB on its own. When disease is strongly suspected or a person is very ill, treatment may begin before all bacteriological results are available, guided by the treating team. This is different from casually prescribing treatment for an unexplained scan finding. Ask which results are preliminary, which are pending, and who will contact you when the remaining results arrive. If a specimen has to be repeated, ask whether the issue is sample quality, timing, an uncertain result or a need to investigate a different body site. [20]

Fungal test interpretation also depends on context. CDC’s histoplasmosis testing guidance notes that early testing can be negative and that some antibody results can reflect a previous infection. Cross-reactions with other fungi may complicate interpretation. A clinician may therefore repeat testing or combine tests rather than treat one result as the entire answer. Tell the team when symptoms began and whether you have already taken antimicrobial treatment. Ask whether the test is looking for part of the organism, an immune response or growth of the organism itself. Those are different types of evidence. If the result and your clinical course do not seem to agree, ask what follow-up is planned rather than concluding either that the test is useless or that it settles everything. [21]

For digestive symptoms suggesting Crohn’s disease, assessment may include blood tests, stool tests, endoscopy and imaging. Blood tests can identify anemia or signs of inflammation, while stool testing can help evaluate inflammation and exclude certain infections. Endoscopy allows clinicians to see the digestive tract and take biopsies. These pieces of information are interpreted together, including where inflammation occurs and whether another condition could explain it. A granuloma mentioned in a bowel sample does not eliminate the need for that wider evaluation. Before the appointment, list medicines, prior infections, family history and the pattern of bowel symptoms. Ask the gastroenterology team which part of the bowel has been examined and whether any additional investigation is needed to understand the full extent of the problem. [22]

Why infection checks matter before treatment

Medicines that reduce immune activity can be useful for inflammatory disease, but they can also increase the risk that an infection becomes active or severe. CDC identifies corticosteroids and some specialized treatments for Crohn’s disease or rheumatoid arthritis among factors that increase the risk of active TB in someone already infected. Before starting such treatment, tell the prescriber about previous TB testing, past treatment, close contact with TB and relevant travel or residence. Ask what infection screening is needed for the particular medicine, not merely whether “all blood tests” were normal. This is a reason for a coordinated plan, not a reason to decline necessary treatment automatically. If a serious inflammatory illness requires urgent care, specialists balance the risks and manage the investigation and treatment accordingly. [23]

Do not self-treat a pathology label. An anti-inflammatory medicine, antibiotic and antifungal solve different problems. Before starting a new treatment, ask: “What diagnosis are we treating, what benefit do we expect, and which important alternatives have been considered?” Keep the answer with your medication list so another clinician can understand the plan.

Treatment follows the confirmed cause

Sarcoidosis and other inflammatory conditions

Not everyone diagnosed with sarcoidosis needs medicine. Treatment decisions depend on symptoms, the organs affected and how well those organs are functioning. When treatment is needed, corticosteroids are commonly used, and other immune-modifying medicines may be considered. The aim is to control disease while limiting treatment harms. Long-term corticosteroid use can affect blood sugar, blood pressure, bones, eyes and mood, among other issues. Ask about the monitoring plan and whether a steroid-sparing approach is appropriate if prolonged treatment is expected. A scan that still shows abnormalities does not tell you by itself whether increasing medication would help. Your clinician should explain the treatment target: protecting a threatened organ, improving function, controlling troublesome symptoms, or a combination of these goals. [24]

Valley fever provides another example of individualized treatment. Many mild infections improve without antifungal medicines, while severe lung disease or infection spreading elsewhere requires treatment. People with particular risk factors may also be offered medication. Recovery can take time, so a clinician may follow symptoms and progress rather than prescribe the same course for everyone. Do not interpret this as permission to leave persistent symptoms unassessed or to stop an existing prescription. Ask why observation or treatment is recommended for you, what improvement should look like, and when the plan will be reviewed. Antifungal treatment for one fungal infection should not be assumed suitable for another organism or another site of infection. [25]

For Crohn’s disease, treatment aims to reduce bowel inflammation, prevent flares and maintain remission. Options include medicines and, when needed, surgery for complications or disease that is not adequately controlled. Steroids are generally used short term rather than as a universal maintenance strategy. Surgery can treat particular problems but is not a cure for Crohn’s disease. The plan depends on disease location, severity, complications and previous treatment response. Ask whether your medicine is intended to induce remission, maintain it, or treat an associated problem such as infection. Keep follow-up appointments even when symptoms improve, and discuss practical barriers such as side effects, cost or difficulty taking treatment. A workable plan is more useful than one you cannot realistically follow. [26]

Care for inherited CGD

CGD care focuses on preventing infections, recognizing them early and managing inflammation. Preventive antibiotics and antifungal medicines are commonly part of specialist care; interferon-gamma may also be used. An abscess can sometimes require drainage, and selected inflammatory problems may need carefully supervised anti-inflammatory treatment. Some people have been treated successfully with stem-cell or bone-marrow transplantation. These are decisions for an experienced team, not consequences of an incidental granuloma on a scan. If you or your child has confirmed CGD, ask for written instructions covering fever, new respiratory symptoms, missed preventive medicine and how to reach the team outside office hours. Make sure other healthcare professionals understand that the condition is an immune disorder and know which treatments you already receive. [27]

An immunology assessment for suspected CGD can include a dihydrorhodamine, or DHR, test that assesses the oxidative-burst function of certain white blood cells. Genetic testing helps identify the molecular cause and inform family counseling. Test interpretation has limitations, so results must be considered with the clinical history rather than read as an isolated yes-or-no answer. Recurrent severe infections, deep abscesses or a suggestive family history can make this investigation relevant. Inheritance differs between genetic forms, and a genetic counselor can explain implications for relatives without assuming that every family member has the condition. Ask for a copy of the confirmed laboratory and genetic findings, especially before transferring care. Ordinary blood counts alone do not provide the same information as these specialized immune-function tests. [28]

Living with a diagnosis or an unfinished investigation

Use medicines safely

If you have been prescribed prednisolone, do not suddenly stop it without speaking to the prescriber. Abrupt withdrawal can be dangerous, particularly after prolonged treatment or higher doses, and the underlying illness can flare. A gradual dose reduction may be needed. Get the schedule in writing and ask what to do if you miss a dose or cannot keep medicine down. Do not make up for a forgotten dose by doubling it unless your clinician specifically directs you. If instructions from two appointments differ, contact the prescribing team or pharmacist to reconcile them. Keep an updated list showing the current dose, not only the original dose, because tapering schedules can otherwise become confusing for you and for clinicians reviewing your care. [29]

Track function, not just scan language

For people living with sarcoidosis, ongoing review remains important even when symptoms are mild or treatment has ended. A flare can occur after remission, and monitoring may also check for medicine-related complications. Fatigue, anxiety or low mood deserve attention rather than being dismissed because a scan is stable. Discuss a suitable activity level, support for stopping smoking, sleep and practical help with daily tasks. New vision changes, sudden breathlessness or sudden weakness need prompt medical attention rather than waiting for the next routine review. Ask which symptoms your own team wants reported immediately. The goal is not to spend every day searching for disease, but to have a clear plan that lets you recognize meaningful changes and know whom to contact. [30]

Nutrition and exposure advice should be specific

There is no reason to assume that one restrictive eating plan is appropriate for every condition described as granulomatous. In Crohn’s disease, reduced appetite, intestinal inflammation and some treatments can affect nutrition. A clinician may recommend an individualized eating plan or supplements when needed. Keeping a food diary can help identify foods associated with symptoms, but eliminating large food groups without a plan can make adequate nutrition harder. Ask for dietitian input if weight is falling, eating has become difficult or you are unsure how to meet your needs. Discuss supplements and alternative products before using them. A food-related symptom change does not, on its own, establish whether the underlying inflammatory disease is controlled. [31]

For people whose work involves contaminated soil or accumulated bird or bat droppings, preventing inhalation of fungal spores is a practical issue. NIOSH describes exposure risks during activities such as disturbing droppings, excavation and demolition. Discuss the task with the employer’s safety or occupational-health team rather than improvising protection or dry-sweeping a heavily contaminated area. Explain any relevant immune condition to your clinician when asking for individualized advice. A recommendation for one person’s workplace exposure should not be generalized into a rule that everyone with an old granuloma must avoid all outdoor activity. The useful question is which exposure poses a risk for your actual condition and what controls or changes are appropriate for that task. [32]

Make pending results easier to follow

An NTM investigation shows why the exact sample and organism matter. Depending on the suspected site, culture may be performed on sputum, airway washings, a wound, tissue or another body fluid. These bacteria include different species with different growth characteristics, so “mycobacteria found” is not a complete explanation of the result. Ask the clinician to distinguish the laboratory finding from the clinical diagnosis. Keep a simple record of which samples were collected, which results are final and whether the team has asked for more specimens. This is particularly useful when a procedure occurred in one hospital and follow-up is happening elsewhere. You do not need to interpret the microbiology yourself; your task is to make sure the responsible clinician reviews the complete result. [33]

Questions to take to your next appointment

Begin with the question that matters most to you: “What do we know so far?” Ask the clinician to separate confirmed facts from possibilities. Then ask what remains uncertain and what the next investigation is expected to clarify. If no further test is recommended, ask why observation is reasonable and what would change that decision. Write the answers in your own words and read them back if anything is unclear. This helps you leave with a plan rather than a collection of unfamiliar terms.

Bring the actual imaging and pathology reports, dates of previous scans, a medication list, and a short timeline of symptoms. Include relevant occupations, travel and procedures. Ask who is coordinating the investigation and who will explain any results that arrive later. Before leaving, confirm the next appointment or review date, the best contact route for questions, and the symptoms that should prompt earlier care. If you have several specialists, request one concise summary that you can share with each team. These steps are especially useful when a report is available in a patient portal before someone has explained it.

The most useful outcome is a specific, understandable care plan. It should tell you whether the finding is thought to be old or active, what cause is established or suspected, whether treatment is needed, and how progress will be assessed. If the only answer you have is “granulomatous disease,” ask for that clarification. A broad label is the beginning of a conversation, not a substitute for an explanation of your own health.

Granuloma Care: Tests and Causes